Presented In Partnership with the Adam Smith Society
Health care costs in the U.S. are some 18 percent of GNP, nearly double what other rich countries spend. We read of drug therapies that cost $100,000 a year or more, and of drug price increases that are 6 times of the rate of inflation, on average, and often way more when mergers reduce competition in the industry. Is this a major driver of excessive health care costs? Or is it a by-product of the huge costs of getting new drugs approved? Has big pharma delivered drugs that reduce the need for costly surgeries, which extend life and improve its quality? Or do they deserve the blame that has been leveled against them?
For the motion:
Ezekiel Emanuel, Oncologist, Bioethicist & Vice Provost, University of Pennsylvania
Neera Tanden, President and CEO, Center for American Progress
Against the motion:
Michael Mandel, Chief Economic Strategist, Progressive Policy Institute
VIP tickets include access to the debate and a private, post-debate reception in honor of the debaters. Immediately following the debate, enjoy a celebratory toast at Craft within blocks of Skirball Center. Meet John Donvan, the debaters, IQ2US council members and other influencers and audience members. Availability is extremely limited. Purchase the General Admission & Private Reception to join.